Work in our laboratory on cyclic conotoxins is supported by grants from the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC). D.J.C. is a NHMRC Principal Research Fellow. R.J.C. is a NHMRC Biomedical Career Development Award Fellow. We gratefully acknowledge access to the facilities of the ARC Special Research Centre for Functional and Applied Genomics.
The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain†
Version of Record online: 17 AUG 2010
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 122, Issue 37, pages 6695–6698, September 3, 2010
How to Cite
Clark, Richard J., Jensen, J., Nevin, Simon T., Callaghan, Brid P., Adams, David J. and Craik, David J. (2010), The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain. Angew. Chem., 122: 6695–6698. doi: 10.1002/ange.201000620
- Issue online: 1 SEP 2010
- Version of Record online: 17 AUG 2010
- Manuscript Revised: 24 MAR 2010
- Manuscript Received: 2 FEB 2010
- Australian Research Council (ARC)
- National Health and Medical Research Council (NHMRC)
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.